## **FIBROID FORUM UK** ## **CHARITABLE INCORPORATED ORGANISATION NO. 1177878** ## **REPORT AND ACCOUNTS** ## **31 DECEMBER 2021** 1 ## **Fibroid Forum UK** ## **Report of the Trustees for the year ending 31 December 2021** The Trustees of the Fibroid Forum UK present their annual report and accounts for the year ended 31 December 2021. The board of trustees are satisfied with the performance of the charity during the year and the position as of 31 December 2021 and consider that the charity is in a good position to continue its activities during the coming year. ## **Charity's Registered Address** 253 Lordship Lane London SE22 8JF The charity is a registered Charitable Incorporated Organisation No. 1177878 ## **A summary of the objects of the charity as set out in its governing document:** The relief of sickness and the preservation of health of women who are suffering or are at risk of suffering from uterine fibroids, in particular but not exclusively by: - (1) raising awareness of fibroids and how it impacts on the lives of sufferers; - (2) educating and empowering women suffering from fibroids to enable them to make informed choices about the best treatment options for them and how to access them; and: - (3) aiding the research of the causes of fibroids to help alleviate and eliminate the condition and to publish the useful results. ## **An explanation of the charity's main activities and objectives for the year** In September 2017, the charity took over running the Guys & St Thomas' quarterly Fibroids Support Group meeting which were originally run at the hospital. In 2020 in the wake of the COVID-19 pandemic and the lockdown restrictions the quarterly meetings moved to the online platform of Zoom which enabled the charity to continue offering this vital support to fibroid sufferers and enabled access to attendees from further afield. These quarterly meetings continued online in 2021. Attendees were required to pre-register to attend and asked to remain on camera during meetings. The support group meetings continued to raise awareness of fibroids and how the condition impacts on the lives of sufferers; educating and empowering women suffering from fibroids to enable them to make informed choices about the best treatment options and how to access them. The meetings also continued to provide a forum for practitioners in the field to share information and expertise on the treatment options available to sufferers. During the course of the year meetings had contributions from practitioners including Bridget Yorke, founder of the Fibroid Network, and Paulette Bassan, a retired nurse and trainer shared a presentation on postoperative care for the condition. The support group meetings have also provided the opportunity for sufferers to share their experience of the condition, the various treatment options that they had undergone, the challenges in obtaining treatment as well as the self-care they have engaged with in treating their condition. Some attendees continue to regularly attend meetings even after receiving treatment and contribute to the group discussion. The charity continues to have a social media presence both on Facebook and Twitter, with the charity's private Facebook group a forum where sufferers of the condition can share their experience, ask questions, and gain support from other sufferers. Articles regarding the condition and other gynaecological conditions are also shared in the Facebook group. Facebook, Twitter, and Eventbrite have also been the means by which support group meetings have been publicised. ## **Structure, Governance and Management** The charity trustees are responsible for the overall management and control of the charity. All decisions are made by the trustees. The trustees met on seven occasions during the year to discuss governance of the charity, plan support group meetings and ways of promoting awareness of fibroids and the treatment options available. ## **Public benefit** The charity's trustees continue to have regards to the Charity Commission's public benefit guidance. The trustees are aware of the guidance and have taken it into account when decision making to which the guidance is relevant in the running of the charity. On any occasion where the trustees decide to depart from the guidance, they have good reasons for doing so and this is recorded. The trustees believe that the charity has continued to provide public benefit through the support group meetings for fibroid sufferers, many of whom have fed back with their appreciation for a supportive forum in which to share their experience with other sufferers as well as gaining information from practitioners in the field, which has enabled them to make better choices about the treatment options available to them. Several of the attendees continue to regularly attend the support group meetings. Public benefit has also been provided through the charity's Facebook group which was established in 2017 and is administered by two of the trustees. At the end of the reporting period the Facebook group had a total of 647 members up from 534 members the previous year. 3 ## **Financial Review & Annual Return Questions** The financial statements are set out in the accounts for the period ending 31 December 2021. The accounts have been presented as a Receipts and Payments Accounts. Funding was raised In 2021 and this is reported in the accounts. Grant making is not the main way that the charity carries out its purposes. During the financial period for this return, the charity received no income or grant funding from contracts from central government or a local authority. During the financial period for this annual return, the charity received no income from outside of the UK. During the financial period for this annual return, the charity did not operate outside England and Wales and no money was spent or transferred outside England and Wales. The charity has no trading subsidiaries. During the financial period for this annual return, none of the trustees received remuneration or benefits other than expenses incurred. None of the trustees were paid: - (a) for being a trustee; - (b) for providing professional advice or services to the charity; or - (c) for any other benefit from the charity (for example accommodation, car, holiday). The charity has no employees or paid members of staff and during the period covered by this annual return, none of the trustees resigned to take up employment with the charity. The charity had no UK volunteers during the financial period. All activities were undertaken by the trustees. The charity has no overseas expenditure and therefore no monitoring controls in place to monitor such expenditure. None of the charity's trustees are in roles within the charity requiring a standard, enhanced, or enhanced with barred lists DBS check. ## **Members of the Board of Trustees at the date the report and the accounts were approved** Audrey Skervin (Chair) Yvonne Maye (Treasurer) Elfreda Skervin Helen Odozi Dawn Martin 27 October 2022 4 |**Charity Name**||**No (if any)**||| |---|---|---|---|---| |**Fibroid Forum UK**||**1177878**||| |**Receipts and payments accounts**||||**CC16a**| |**For the period**
**from**|Period start date
01/01/2021|Period end date
**To**
31/12/2021||| |**Section A Receipts and payments**|**Section A Receipts and payments**||||| |---|---|---|---|---|---| |**A1 Receipts**|**Unrestricted**
**funds**
**to the nearest £**
**40**
**-**
**-**
**-**
**-**
**-**
**-**
**-**

**40**
**-**
**-**
**-**
**40**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**40**
**-**
**-**
**40**|**Restricted**
**funds**
**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**Endowment**
**funds**
**to the nearest £**|**Total funds**
**to the nearest £**
**40**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**40**
**-**
**-**
**-**
**40**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**40**|**Last year**
**to the nearest £**| ||**40**||**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**||**220**| ||**-**||||**-**| ||**-**||||**-**| ||**-**||||**-**| ||**-**||||**-**| ||**-**||||**-**| ||**-**||||**-**| ||**-**||||**-**| |**_Sub total_**_(Gross income for_
_AR)_|
**40**||||**220**| ||||||| |**A2 Asset and investment sales,**
**(see table).**|||||| ||**-**||**-**
**-**
**-**||| ||**-**||||**-**| |**_Sub total_**|**-**||||**-**| |**_Total receipts_**
**A3 Payments**|||||| ||||**-**||**220**| ||||||| ||**-**||**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**||**-**| ||**-**||||**-**| ||**-**||||**-**| ||**-**||||**-**| ||**-**||||**-**| ||**-**||||**-**| ||**-**||||**-**| ||**-**||||**-**| ||**-**||||**-**| |**_Sub total_ **|**-**||||**-**| ||||||| |**A4 Asset and investment**
**purchases (see table)**|||||| |**,**|**-**||**-**
**-**
**-**||| ||**-**||||| |**_Sub total_ **|**-**||||**-**| |**_Total payments_**
**_Net of receipts/(payments)_**
**A5 Transfers between funds**
**A6 Cash funds last year end**
**_Cash funds this year end_**|||||| ||||**-**||**-**| ||||||| ||**40**||
**-**||**220**| ||**-**||**-**
**-**|**-**
**-**|**-**| ||**-**||||**-**| ||**40**||
**-**|**40**|**220**| CCXX R1 accounts (SS) 27/10/2022 1 **Section B Statement of assets and liabilities at the end of the period** |**Categories**
Signed by one or two trustees on
behalf of all the trustees
**B5 Liabilities**
**B3 Investment assets**
**B2 Other monetary assets**
**B4 Assets retained for the**
**charity’s own use**
**B1 Cash funds**|**Details**
**Details**
**_Total cash funds_**
(agree balances with receipts and payments
account(s))
**Details**
**Details**
**Details**
Signature
Dawn Martin|**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**40**
**-**
**-**
**-**
**-**
**-**
**40**
**-**
OK
OK
**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**liability relates**
**Amount due**
**(optional)**
**-**
**-**
**-**
**-**
**-**
Print Name
Dawn Martin|**Endowment**
**funds**
**to nearest £**| |---|---|---|---| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||OK| ||||**Endowment**
**funds**
**to nearest £**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**Current value**
**(optional)**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**Current value**
**(optional)**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**When due**
**(optional)**| ||||| ||||| ||||| ||||| ||||| ||||| ||||Date of
approval| ||Dawn Martin|Dawn Martin|27/10/2022| ||||| CCXX R2 accounts (SS) 27/10/2022 2